← All companies
XENE
Xenon Pharmaceuticals Inc.
$62.26
-1.93 -3.01%
Key statistics
from XBRL data in SEC filingsMarket cap
$6.02B
Revenue (TTM)
$0.00
Net income (TTM)
-$383M
EPS (TTM)
$-4.70
P/E ratio
—
Dividend yield
—
Free cash flow
-$280M
Cash
$546M
Total assets
$1.39B
Gross margin
—
52-week range
$30.65 – $72.66
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change; Shareholder vote results
Jun 3, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 7, 2026
8-K
Director or officer change
Apr 13, 2026
8-K
Other events
Mar 13, 2026
8-K
Entered a material agreement; Other events
Mar 12, 2026
8-K
Regulation FD disclosure
Mar 9, 2026
8-K
Other events
Feb 27, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 26, 2026
8-K
Director or officer change
Dec 1, 2025
10-Q
Quarter ended 2025-09-30
Nov 3, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 3, 2025
8-K/A
Director or officer change; Other events
Oct 17, 2025
8-K
Director or officer change
Oct 16, 2025
10-Q
Quarter ended 2025-06-30
Aug 11, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 11, 2025
8-K
Director or officer change
Jul 3, 2025
8-K
Shareholder vote results
Jun 5, 2025
10-Q
Quarter ended 2025-03-31
May 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 12, 2025
8-K
Other events
Mar 17, 2025
8-K
Changed accountants
Mar 5, 2025
10-K
Fiscal year ended 2024-12-31
Feb 27, 2025
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Feb 27, 2025
8-K
Director or officer change
Jan 17, 2025
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 12, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 8, 2024
8-K
Shareholder vote results
Jun 5, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
May 9, 2024
8-K
Director or officer change
Apr 19, 2024
8-K
Other events
Mar 8, 2024
10-K
Fiscal year ended 2023-12-31
Feb 29, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 29, 2024
8-K
Entered a material agreement; Other events
Nov 30, 2023
8-K
Other events
Nov 27, 2023
8-K
Other events
Nov 9, 2023